In Vivo Performance and Properties of Tamoxifen Metabolites for CreERT2 Control.
Felker A, Nieuwenhuize S, Dolbois A, Blazkova K, Hess C, Low LW, Burger S, Samson N, Carney TJ, Bartunek P, Nevado C, Mosimann C.
Felker A, et al. Among authors: carney tj.
PLoS One. 2016 Apr 14;11(4):e0152989. doi: 10.1371/journal.pone.0152989. eCollection 2016.
PLoS One. 2016.
PMID: 27077909
Free PMC article.